Charles BELL
4Patents
2h-index
19Co-inventors
34Inventor score
Filing activity: Mar 23, 2020 → Sep 26, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11390610B2 | Piperazine derivatives as MAGL inhibitors | Chemistry; Metallurgy | 5 | Active |
| US11420961B2 | Heterocyclic compounds | Chemistry; Metallurgy | 5 | Active |
| US11802133B2 | Heterocyclic compounds as monoacylglycerol lipase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US12281124B2 | Heterocyclic compounds as monoacylglycerol lipase inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.